Related Experiment Video
Updated: Sep 14, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
EuroSCORE II: Current limitations and physiological gaps in risk stratification
Jing Yong Ng1, Eu Fon Tan2, Marsioleda Kemberi1
1Barts Heart Centre, St Bartholomew's Hospital, London, UK.
The current EuroSCORE II model for cardiac surgery risk has limitations. Enhancements incorporating frailty, advanced metrics, and machine learning could improve its accuracy for better patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Medical Informatics
- Health Services Research
Background:
- Cardiac surgery risk stratification is crucial for patient management.
- The European System for Cardiac Operative Risk Evaluation (EuroSCORE) II (2011) is a key tool but has limitations.
- Evolving surgical practices and patient populations necessitate model updates.
Purpose of the Study:
- To identify limitations in the current EuroSCORE II predictive model.
- To explore potential enhancements for improved risk stratification accuracy.
- To propose directions for a next-generation cardiac surgery risk score.
Main Methods:
- Analysis of EuroSCORE II's current variables and their limitations.
- Identification of underrepresented patient factors (frailty, race, liver dysfunction).
- Exploration of advanced cardiac function metrics (e.g., GLS) and scoring systems (e.g., SYNTAX, MELD).
- Consideration of machine learning integration for enhanced prediction.
Main Results:
- EuroSCORE II omits critical factors like frailty, race, and detailed cardiac/liver function.
- The model inadequately addresses complex conditions like infective endocarditis and coronary artery disease severity.
- Advanced parameters and machine learning offer potential for greater predictive granularity.
Conclusions:
- EuroSCORE II requires updates to reflect contemporary cardiac surgery.
- Incorporating underrepresented variables and advanced metrics can improve risk prediction.
- A future 'EuroSCORE III' leveraging machine learning could enhance personalized care and patient outcomes.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Coronary Artery Disease I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Bias in Epidemiological Studies

